Quick Answer
EXOZYMES INC. reported Diluted EPS of $1.09 per share (loss) for fiscal year 2025.
EXOZYMES INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.09 | -22.5% |
| 2024 | -$0.89 | -169.7% |
| 2023 | -$0.33 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.27 | +0.0% | +3.6% |
| June 30, 2025 | -$0.28 | -27.3% | -27.3% |
| March 31, 2025 | -$0.22 | -37.5% | +18.5% |
| September 30, 2024 | -$0.27 | -237.5% | -22.7% |
| June 30, 2024 | -$0.22 | — | -37.5% |
| March 31, 2024 | -$0.16 | — | -100.0% |
| September 30, 2023 | -$0.08 | — | — |
- EXOZYMES INC. showed a decrease of -22.5% in Diluted EPS compared to the prior fiscal year.
- Over the 2023–2025 period, EXOZYMES INC.’s diluted eps has declined by 230.3% (from $0.33 per share (loss) to $1.09 per share (loss)).
- The most recent figure is from EXOZYMES INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: